These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30130683)

  • 21. PSA screening among elderly men with limited life expectancies.
    Walter LC; Bertenthal D; Lindquist K; Konety BR
    JAMA; 2006 Nov; 296(19):2336-42. PubMed ID: 17105796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
    Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
    Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the 2008 U.S. Preventative Services Task Force recommendation on frequency of prostate-specific antigen screening in older men.
    Lee SY; Friderici J; Stefan MS; Rothberg MB
    J Am Geriatr Soc; 2014 Oct; 62(10):1912-5. PubMed ID: 25284269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
    Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
    Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
    Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline.
    Jiang C; Fedewa SA; Wen Y; Jemal A; Han X
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):77-80. PubMed ID: 32296126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPs views and understanding of PSA testing, screening and early detection; survey.
    Sutton J; Melia J; Kirby M; Graffy J; Moss S
    Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PSA testing for men at average risk of prostate cancer.
    Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia.
    Dantanarayana ND; Hossack T; Cozzi P; Brooks A; Lau H; Delprado W; Patel MI
    BMC Urol; 2015 Dec; 15():124. PubMed ID: 26715039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.
    Perez TY; Danzig MR; Ghandour RA; Badani KK; Benson MC; McKiernan JM
    Urology; 2015 Jan; 85(1):85-9. PubMed ID: 25440819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Li J; Zhao G; Hall IJ
    Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice.
    Wilt TJ; Dahm P
    J Natl Compr Canc Netw; 2015 Dec; 13(12):1566-74. PubMed ID: 26656523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen testing practices and outcomes.
    Hoffman RM; Blume P; Gilliland F
    J Gen Intern Med; 1998 Feb; 13(2):106-10. PubMed ID: 9502370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.
    Fedewa SA; Gansler T; Smith R; Sauer AG; Wender R; Brawley OW; Jemal A
    Ann Fam Med; 2018 Mar; 16(2):139-144. PubMed ID: 29531105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011.
    Nordström T; Aly M; Clements MS; Weibull CE; Adolfsson J; Grönberg H
    Eur Urol; 2013 Mar; 63(3):419-25. PubMed ID: 23083803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Focus on the screening for prostate cancer by PSA].
    Roumeguère T; Van Velthoven R
    Rev Med Brux; 2013 Sep; 34(4):311-9. PubMed ID: 24195246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
    Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
    Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016.
    Molazem Z; Ebadi M; Khademian M; Zare R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):633-637. PubMed ID: 29580031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline PSA in a Spanish male population aged 40-49 years anticipates detection of prostate cancer.
    Angulo JC; Viñas MA; Gimbernat H; Fata FR; Granados R; Luján M
    Actas Urol Esp; 2015 Dec; 39(10):605-11. PubMed ID: 26099906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.